[3] Renal dysfunction is a relative contraindication: May increase the percent of free fosphenytoin
Sobo will review your medical history, goals, current medications, weight history, and risk factors to determine whether GLP-1 therapy is appropriate
The Proglucagon Family All three peptidesGLP-1, GLP-2, and GLP-3come from the same genetic source but are processed differently: In the pancreas: Proglucagon is processed to produce glucagon In the intestines: Proglucagon is processed to produce GLP-1, GLP-2, and other peptides In the brain: Similar processing occurs with various effects on appetite and metabolism Now, lets explore each peptide individually to understand their unique characteristics
Thats because, for all their efficacy in suppressing appetite and slowing gastric emptying, GLP-1 agonists dont show people how to eat in a healthy, sustainable way, nor do they inspire people to increase activity levels